An update on the pathogenesis, inflammation, and metabolism in hirsutism and polycystic ovary syndrome

被引:133
作者
Glintborg, Dorte [1 ]
Andersen, Marianne [1 ]
机构
[1] Odense Univ Hosp, Dept Endocrinol, DK-5000 Odense, Denmark
关键词
Polycystic ovary syndrome; hirsutism; androgens; insulin resistance; pituitary gland; BONE-MINERAL DENSITY; IMPAIRED GLUCOSE-TOLERANCE; INSULIN-RESISTANCE; PIOGLITAZONE TREATMENT; ANDROGEN EXCESS; WEIGHT-LOSS; DEHYDROEPIANDROSTERONE-SULFATE; SERINE PHOSPHORYLATION; LUTEINIZING-HORMONE; CORTISOL METABOLISM;
D O I
10.3109/09513590903247873
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hirsutism is a common endocrine disorder, defined as increased growth of terminal hairs in a male pattern. Hirsutism is most often caused by polycystic ovary syndrome (PCOS), whereas only 5% patients are diagnosed with rare endocrine diseases. PCOS may be considered a multiorgan disease causing not only increased adrenal and ovarian sex hormone secretion but also changed secretion of gonadotrophins, growth hormone, and adrenocorticotrophic hormone (ACTH) from the pituitary. The majority of patients with PCOS are insulin resistant and PCOS is characterized by an increased inflammatory state with abdominal obesity and increased secretion of interleukins, chemokines, and adipokines. PCOS is therefore associated with an increased risk of the metabolic syndrome and type 2 diabetes (T2D). Patients with hirsutism present with increased bone mineral density despite decreased D-vitamin levels. The etiology to hirsutism and PCOS is most likely multifactorial including both genetic and environmental factors such as increased fetal stress and intrauterine growth retardation. In the present review, we give a comprehensive overview of the pathophysiology and multiple endocrine disturbances of hirsutism and PCOS.</.
引用
收藏
页码:281 / 296
页数:16
相关论文
共 78 条
[21]   SUPPRESSION OF HYPERANDROGENISM DOES NOT IMPROVE PERIPHERAL OR HEPATIC INSULIN RESISTANCE IN THE POLYCYSTIC OVARY SYNDROME [J].
DUNAIF, A ;
GREEN, G ;
FUTTERWEIT, W ;
DOBRJANSKY, A .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1990, 70 (03) :699-704
[22]   DETECTION OF FUNCTIONAL OVARIAN HYPERANDROGENISM IN WOMEN WITH ANDROGEN EXCESS [J].
EHRMANN, DA ;
ROSENFIELD, RL ;
BARNES, RB ;
BRIGELL, DF ;
SHEIKH, Z .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (03) :157-162
[23]   Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome [J].
Ehrmann, DA ;
Barnes, RB ;
Rosenfield, RL ;
Cavaghan, MK ;
Imperial, J .
DIABETES CARE, 1999, 22 (01) :141-146
[24]   The polycystic ovary syndrome associated with morbid obesity may resolve after weight loss induced by bariatric surgery [J].
Escobar-Morreale, HF ;
Botella-Carretero, JI ;
Alvarez-Blasco, F ;
Sancho, J ;
San Millán, JL .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (12) :6364-6369
[25]   The molecular-genetic basis of functional hyperandrogenism and the polycystic ovary syndrome [J].
Escobar-Morreale, HF ;
Luque-Ramírez, M ;
San Millán, JL .
ENDOCRINE REVIEWS, 2005, 26 (02) :251-282
[26]   Adrenarche and fetal growth [J].
Francois, I ;
deZegher, F .
PEDIATRIC RESEARCH, 1997, 41 (03) :440-442
[27]   Augmented frequency and mass of LH discharged per burst are accompanied by marked disorderliness of LH secretion in adolescents with polycystic ovary syndrome [J].
García-Rudaz, MC ;
Ropelato, MG ;
Escobar, ME ;
Veldhuis, JD ;
Barontini, M .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1998, 139 (06) :621-630
[28]   Evidence for a primary abnormality of thecal cell steroidogenesis in the polycystic ovary syndrome [J].
GillingSmith, C ;
Story, H ;
Rogers, V ;
Franks, S .
CLINICAL ENDOCRINOLOGY, 1997, 47 (01) :93-99
[29]   Fetal plasma testosterone correlates positively with cortisol [J].
Gitau, R ;
Adams, D ;
Fisk, NM ;
Glover, V .
ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 2005, 90 (02) :166-169
[30]   Pioglitazone treatment increases spontaneous growth hormone (GH) secretion and stimulated GH levels in polycystic ovary syndrome [J].
Glintborg, D ;
Stoving, RK ;
Hagen, C ;
Hermann, AP ;
Frystyk, J ;
Veldhuis, JD ;
Flyvbjerg, A ;
Andersen, M .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (10) :5605-5612